FDA frees Abbott's Liberta RC DBS system for use : vimarsana

Abbott Laboratories received U.S. FDA clearance for its Liberta RC deep brain stimulation (DBS) system for use in movement disorders, less than two weeks after the agency gave its nod to Medtronic’s Percept RC DBS system. The news come on the heels of Abbott’s release of strong fourth quarter results on Wednesday.

Related Keywords

, Abbott Laboratories , Bioworld Medtech , 510k Clearance , Parkinsons Disease , Essential Tremor , Abbott Laboratories Inc , Medtronic Plc , Boston Scientific Corp , Aleve Neurotherapeutics Sa , Brainlab Ag , Deep Brain Stimulation , Dbs , Regulatory , Neurology Psychiatric , Us , Fda ,